• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视这个问题:37摄氏度孵育后的血清学反应性读数能否省略?

Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?

作者信息

Judd W J, Fullen D R, Steiner E A, Davenport R D, Knafl P C

机构信息

Blood Bank, Department of Pathology, University of Michigan Health System, Ann Arbor 48108, USA.

出版信息

Transfusion. 1999 Mar;39(3):295-9. doi: 10.1046/j.1537-2995.1999.39399219287.x.

DOI:10.1046/j.1537-2995.1999.39399219287.x
PMID:10204593
Abstract

BACKGROUND

Omitting the 37 degrees C reading from screening tests for unexpected antibodies results in failure to detect some Rh, K, and Jk agglutinins of potential significance (wanted positives). However, this measure avoids unwanted positive tests due to cold agglutinins.

STUDY DESIGN AND METHODS

Using data from prior publications, actual risk calculations (ARCs) were made to predict the risk of eliminating the 37 degrees C reading, pretransfusion direct antiglobulin test (DAT), and routine indirect antiglobulin crossmatch (IAT-XM). ARCs used the equation: wanted positives missed x 0.34 (or 0.80) x 5 x percent antigen-positive, where 0.34 = percent of patients transfused (ARCs for 37 degrees C reading and DAT); 0.80 = percent of crossmatched patients transfused (ARCs for IAT-XM); 5 = average number of units transfused. Following elimination of the 37 degrees C reading, the impact of this change on patient care was monitored. Antibody detection and identification data and transfusion reaction reports for 6 months after the change were reviewed. Recently transfused patients with new antibodies were evaluated for immune hemolysis by review of clinical and laboratory data. The findings were compared with those from the same dates of the preceding year.

RESULTS

The risk of transfusing incompatible blood by eliminating the DAT, IAT-XM, and 37 degrees C reading is approximately 1:13,000, 1:2,000, and 1:2,400 units transfused, respectively. The cumulative risk from eliminating all three tests is approximately. 1 :1,000 units. With respect to the 37 degrees C reading, there were no differences between the pre-change and post-change study periods in the incidence of reported transfusion reactions or cases of immune hemolysis associated with newly formed antibodies. However, unwanted positive tests decreased from 162 to 61 following elimination of the 37 degrees C reading. This represents a decrease of 20 percent in the number of samples requiring antibody identification annually.

CONCLUSIONS

Eliminating the 37 degrees C reading from pretransfusion antibody screening tests imposes less risk than omitting the routine IAT-XM, and it avoids the time and costs of evaluating unwanted positive tests, thus reducing expenditures and delays in patient care.

摘要

背景

在意外抗体筛查试验中省略37℃读数会导致无法检测到一些具有潜在重要意义的Rh、K和Jk凝集素(所需阳性结果)。然而,这一措施可避免因冷凝集素导致的不必要阳性试验。

研究设计与方法

利用先前出版物中的数据进行实际风险计算(ARC),以预测省略37℃读数、输血前直接抗球蛋白试验(DAT)和常规间接抗球蛋白交叉配血试验(IAT-XM)的风险。ARC使用的公式为:漏检的所需阳性结果数×0.34(或0.80)×5×抗原阳性百分比,其中0.34 = 输血患者百分比(37℃读数和DAT的ARC);0.80 = 交叉配血患者输血百分比(IAT-XM的ARC);5 = 平均输血量。省略37℃读数后,监测这一变化对患者护理的影响。回顾了变化后6个月的抗体检测与鉴定数据以及输血反应报告。通过回顾临床和实验室数据,对近期输血且产生新抗体的患者进行免疫溶血评估。将结果与上一年同期的结果进行比较。

结果

省略DAT、IAT-XM和37℃读数而输注不相容血液的风险分别约为每输注13000、2000和2400单位血液出现1例。省略所有三项检测的累积风险约为每1000单位血液出现1例。关于37℃读数,在报告的输血反应发生率或与新形成抗体相关的免疫溶血病例方面,变化前和变化后的研究期间没有差异。然而,省略37℃读数后,不必要的阳性试验从162例降至61例。这意味着每年需要进行抗体鉴定的样本数量减少了20%。

结论

在输血前抗体筛查试验中省略37℃读数所带来的风险低于省略常规IAT-XM,并且避免了评估不必要阳性试验的时间和成本,从而减少了支出并缩短了患者护理的延迟时间。

相似文献

1
Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?重新审视这个问题:37摄氏度孵育后的血清学反应性读数能否省略?
Transfusion. 1999 Mar;39(3):295-9. doi: 10.1046/j.1537-2995.1999.39399219287.x.
2
Antibody screening: elimination of another piece of the test.
Transfusion. 1999 Mar;39(3):229-30. doi: 10.1046/j.1537-2995.1999.39399219277.x.
3
Can the reading for serologic reactivity following 37 degrees C incubation be omitted?37摄氏度孵育后的血清学反应性读数可以省略吗?
Transfusion. 1992 May;32(4):304-8. doi: 10.1046/j.1537-2995.1992.32492263441.x.
4
Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.使用低离子强度盐水-白蛋白增强介质及缩短孵育时间的间接抗球蛋白试验交叉配血:检测大多数临床显著抗体的有效性及对血液利用的影响
Immunohematology. 2014;30(1):1-5.
5
[Evaluation of the polyethyleneglycol antiglobulin test in the detection and identification of erythrocyte antibodies].[聚乙二醇抗球蛋白试验在红细胞抗体检测与鉴定中的评估]
Sangre (Barc). 1998 Feb;43(1):21-4.
6
A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.一项旨在确定在输血前检测中省略抗球蛋白交叉配血安全性的前瞻性研究。
Br J Haematol. 1992 Aug;81(4):579-84. doi: 10.1111/j.1365-2141.1992.tb02995.x.
7
Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.抗体筛查和即刻离心交叉配血后迟发性溶血性输血反应的发生率
Transfusion. 1992 Nov-Dec;32(9):814-7. doi: 10.1046/j.1537-2995.1992.32993110751.x.
8
Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?自身抗体或临床意义不显著的同种抗体患者是否需要进行间接抗球蛋白试验交叉配血?
Transfusion. 2007 Jul;47(7):1290-5. doi: 10.1111/j.1537-2995.2007.01272.x.
9
Experience with the routine use of an abbreviated crossmatch.常规使用简化交叉配血试验的经验
Am J Clin Pathol. 1984 Aug;82(2):178-81. doi: 10.1093/ajcp/82.2.178.
10
The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.输血前检测中直接抗球蛋白试验阳性(自身对照)的评估再探讨。
Transfusion. 1986 May-Jun;26(3):220-4. doi: 10.1046/j.1537-2995.1986.26386209372.x.

引用本文的文献

1
Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.不完全抗体可能减少ABO血型交叉配血不相容性:一项初步研究。
Turk J Haematol. 2018 Mar 1;35(1):54-60. doi: 10.4274/tjh.2016.0504. Epub 2017 May 23.